Dysphagia and the Management of Patients in Need of Lipid-Lowering
Published: 20 July 2022
-
Views:
3516
-
Likes:
7
-
Views:
3516
-
Likes:
7
-
18m 47sPart 1 Medicines and Dysphagia Yassir Javaid, Nina Barnett, Paresh Parmar
-
11m 33sPart 2 Importance of Maintaining Lipid Lowering Treatment Yassir Javaid
-
13m 17sPart 3 Strategies to Manage Dysphagia and Medication Paresh Parmar
Overview
This virtual round table series focuses on dysphagia and the management of patients in need of lipid-lowering medications. The first three sessions of this video series are presented by Dr Yassir Javaid (Northamptonshire CCG, UK), Prof Nina Barnett (London North West University Healthcare NHS Trust, UK) and Mr Paresh Parmar (London North West Healthcare NHS Trust, UK) followed by session four, a faculty discussion on patient case study.
Dysphagia is a life-threatening disorder that can be caused by a number of conditions, such as stroke, neurological disorders and tumours. By participating in this series, you will gain further insight into the diagnosis of dysphagia, medication adherence, the importance of lipid management and individualising your treatment approach. The renowned faculty will also present and discuss a real-life clinical study.

Key Learning Objectives
- Identify patient subgroups who need encouragement with medicine adherence
- Discuss the importance of maintaining statin treatment in patients at cardiovascular risk
- Recall emerging strategies for dysphagia
- Implement an individualised management approach for patients
Target Audience
- General practitioners
- Pharmacists
- Nurses
- HCPs
More from this programme
Part 1
Medicines and Dysphagia
1 session | |
Medicines and Dysphagia | Watch now |
Part 2
Importance of Maintaining Lipid Lowering Treatment
Part 3
Strategies to Manage Dysphagia and Medication
Part 4
Case Study and Faculty Discussion
1 session | |
Case Study and Faculty Discussion | Watch now |
Faculty Biographies

Yassir Javaid
GPwSI Cardiology
Dr Yassir Javaid, Cardiovascular & Diabetes Lead Northamptonshire CCG, UK. Qualified from Cambridge University and completed his GP VTS training in Northampton. He has an interest in cardiology and echocardiography and was a clinical lead in the Northamptonshire Community Cardiology service, which had a focus on patients with heart failure and valve disease. Dr Javaid was named Pulse “GP of the Year” in 2015 for his work in reducing stroke emergency admissions in the East Midlands. He is also a council member of the British Heart Valve Society, accredited member of the British Society of Echocardiography and on the editorial board for the British Journal of Cardiology.

Nina Barnett
Consultant Pharmacist, Care of Older People
Prof Nina Barnett is a Consultant Pharmacist in care of older people at London North West hospital and Visiting Professor at Kingston University London, UK, with over 25 years’ experience. She delivers outstanding medicines-related coaching, mentoring and education using a person-centred approach. Her areas of expertise as a consultant pharmacist in care of older people include polypharmacy, deprescribing, multi-morbidity and shared decision making. Prof Nina Barnett is an invited speaker and frequently published in leading journals. She contributes at a strategic national level for example, with National Institute for Health and Care Excellence (NICE) and with leading clinicians in the UK.

Paresh Parmar
Clinical Lead Pharmacist, Care of Older People & Stroke
Paresh Parmar is an experienced Lead Clinical Pharmacist at London North West Healthcare NHS Trust, UK, with a demonstrated history of working in the hospital and healthcare industry. Skilled in Healthcare, Clinical Research, Medicine, and Clinical Trials. Paresh Parmar is a strong research professional with a Non-Medical Independent Prescribing focused on Secondary Prevention of Stroke from Kings College London. As lead pharmacist for stroke, he is actively involved in ward pharmacy services and advising prescribers on the appropriate medication for patients with dysphagia, complex co-morbidities and reduced renal and hepatic function.